Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome
AJNR 39:824-829, Zhang, T.,et al, 2018
Value of MRI of the Brain in Patients with Systemic Lupus Erythematosus and Neurologic Disturbance
Neuroradiol 46:15-21, Jennings, J.E.,et al, 2014
Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024
A 12-year-old girl with headache and change in mental status
Neurol 90:524-529, Patel, P.,et al, 2018
Infliximab for the Treatment of CNS Sarcoidosis
Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017
Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016
Autoimmune Post-Herpes Simplex Encephalitis of Adults and Teenagers
Neurol 85:1736-1743, 1730, Armangue, T.,et al, 2015
Hashimotos Encephalopathy: A Report of Three Cases and Relevant Literature Reviews
Int J Clin Exp Med 8:16817-16826, Zhu, Y.,et al, 2015
Evaluation of a Patient with Spinal Cord Infarction after a Hypotensive Episode
Stroke 45:e203-e205, Vongveeranonchai, N.,et al, 2014
PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012
Whipple Limbic Encephalitis
Arch Neurol 68:1471-1473, Blanc, F.,et al, 2011
Acute Necrotizing Encephalopathy in a Child during the 2009 Influenza A(H1N1) Pandemia: MR Imaging in Diagnosis and Follow-up
AJNR 31:396-400, 393, Ormitti,F.,et al, 2010
Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome: Frequency, Features, and Risk Factors
Stroke 41:2505-2511, 2455, Ducros,A.,et al, 2010
Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome Without Tumor Removal
Neurol 70:504-511,500, Iizuka,T.,et al, 2008
When to Expect Negative Diffusion-Weighted Images in Stroke and Transient Ischemic Attack
Stroke 39:1898-1900, Sylaja,P.N.,et al, 2008
MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006
Cliniclopath Conf., Granulomatous Amebic Encephalitis Due to Acanthamoeba
NEJM 355:2678-2689, Case 39-2006, 2006
Primary Angiitis of the Central Nervous System: Emerging Variants
Q J Med 98:643-654, Maclaren,K.,et al, 2005
Angiography-Negative Primary Central Nervous System Vasculitis in Children
Arthritis Rheum 52:2159-2167, Benseler, S.M.,et al, 2005
Clinically Mild Encephalitis Encephalopathy with a Reversible Splenial Lesion
Neurol 63:1854-1858, Tada,H.,et al, 2004
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
Vasogenic Edema in Bickerstaff's Brainstem Encephalitis
Neurol 61:836-838, Weidauer,S.,et al, 2003
Magnetic Resonance Imaging in the Clinical Diagnosis of Creutzfeldt-Jakob Disease
Arch Neurol 57:1751-1757, Schroter,A.,et al, 2000
Tectal Gliomas: Natural History of an Indolent Lesion in Pediatric Patients
Pediatr Neurosurg 32:24-29, Bowers,D.C.,et al, 2000
MR of CNS Sarcoidosis:Correlation of Imaging Features to Clinical Symptoms and Response to Treatment
AJNR 20:655-669, Christoforidis,G.A.,et al, 1999
Susac Syndrome
Medicine 77:3-11, Papo,T.,et al, 1998
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Magnetic Resonance Imaging of Limbic Encephalitis
Neuroradiology 33:520-523, Kodama,T.,et al, 1991
Evolution of Brain MRI Abnormalities in Limbic Encephalitis
Neurol 40:1304-1306, Dirr,L.Y.,et al, 1990